← TrialMatch
HomeTrials

18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEM

The project will be performed over a period of approximately two years. In the first year the \[18F\]FTHA tracer will be developed, optimized, and tested on normal volunteers. During the second year, the tracer will be investigated on patients with suspected obstruction of the thoracic duct (TD).

Condition(s)Lymphatic Obstruction
StatusRecruiting
PhaseEARLY_Phase 1
Study typeInterventional
SummaryThe project will be performed over a period of approximately two years. In the first year the \[18F\]FTHA tracer will be developed, optimized, and tested on normal volunteers. During the second year, the tracer will be investigated on patients with suspected obstruction of the thoracic duct (TD).
Who can participateInclusion Criteria: Inclusion Criteria (Healthy Volunteer Cohort) 1. Male and female participants will be ≥ 18 years of age. 2. "Healthy Volunteer" is defined for the purposes of this study as a volunteer who is in good general health in the opinion of an investigator (some well controlled chronic medical conditions may be allowed at the discretion of an investigator if they do not believe they will interfere with the collection of imaging data, specific excluded medical conditions are listed under exclusion criteria). 3. Informed of the investigational nature of this study and able to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures. Inclusion (Patient with suspected TD-venous junction
Ages18 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorUniversity of Pennsylvania
LocationsPhiladelphia, Pennsylvania, United States
Start date2025-10-10
NCT IDNCT07645573
Official listinghttps://clinicaltrials.gov/study/NCT07645573

🔍 Search all trials →